GLP-1 Medications and Medical Scan Results
Researchers found that GLP-1 drugs, such as Ozempic and Wegovy, may alter PET and CT scan results, risking misdiagnosis.
Experts call for more research and guidance on the unexpected side effect associated with GLP-1 agonists, including popular diabetes and obesity medications like Ozempic, Wegovy, Mounjaro, and Zepbound.
These treatments can interfere with medical imaging techniques, particularly PET and CT scans, which provide detailed internal images and assess organ and tissue function.
- CT scans detect injuries, tumors, and other medical conditions.
- PET scans examine organ and tissue function, assess cancer activity, and monitor treatment responses.
A recent case review was presented at the 38th Annual Congress of the European Association of Nuclear Medicine in Barcelona, Spain.
Author's summary: GLP-1 medications may affect scan results.